Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial

The multi-center, randomized, open-label, phase III trial discussed in the present study was performed to compare the clinical outcomes of nedaplatin (NDP) plus paclitaxel, and carboplatin (CBP) plus paclitaxel for the treatment of epithelial ovarian cancer (EOC). In the current study, 182 patients...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Li, Li, Zhuang, Qingqing, Cao, Zeyi, Yin, Rutie, Zhu, Yaping, Zhu, Lirong, Xie, Xing, Zhang, Youzhong, Wu, Qiang, Zheng, Jianhua, Zhou, Qi, Li, Xiaoping, Wu, Lingying, Feng, Youji, Wang, Changyu
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2018
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796383/
https://ncbi.nlm.nih.gov/pubmed/29467885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7761
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi